0001127602-24-011814.txt : 20240402 0001127602-24-011814.hdr.sgml : 20240402 20240402160631 ACCESSION NUMBER: 0001127602-24-011814 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240401 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Timothy Eugene CENTRAL INDEX KEY: 0001707000 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 24814216 MAIL ADDRESS: STREET 1: 800 BOYLSTON ST., SUITE 3310 STREET 2: PRUDENTIAL TOWER C/O AJU IB INVESTMENT CITY: BOSTON STATE: MA ZIP: 02199 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-04-01 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001707000 Sullivan Timothy Eugene C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 Chief Financial Officer 1 Common Stock 2024-04-01 4 M 0 4000 10.03 A 97338 D Common Stock 2024-04-01 4 S 0 4000 58.66 D 93338 D Common Stock 56232 I The Timothy E Sullivan Irrevocable Trust of 2023 Stock Option (Right to Buy) 10.03 2024-04-01 4 M 0 4000 0 D 2027-10-18 Common Stock 4000 257903 D This is a scheduled exercise & sale from 10b5-1 trading plan dated 12/1/23. The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein. This option was granted on October 18, 2017 and fully vested. /s/s David Watson, attorney-in-fact for Timothy Sullivan 2024-04-02